FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.

Authors

Kaku A. So-Armah
Joseph K. Lim
Vincent Lo Re
Janet P. Tate
Chung-Chou H. Chang
Adeel A. Butt
Cynthia L. Gibert, George Washington University
David Rimland
Vincent C. Marconi
Matthew Bidwell Goetz
Vasan Ramachandran
Evan Brittain
Michelle Long
Kim-Lien Nguyen
Maria C. Rodriguez-Barradas
Matthew J. Budoff
Hilary A. Tindle
Jeffrey H. Samet
Amy C. Justice
Matthew S. Freiberg

Document Type

Journal Article

Publication Date

2-14-2020

Journal

Progress in Cardiovascular Diseases

DOI

10.1016/j.pcad.2020.02.010

Comments

Online ahead of print

APA Citation

So-Armah, K. A., Lim, J. K., Re, V. L., Tate, J. P., Chang, C. H., Butt, A. A., Gibert, C. L., Rimland, D., Marconi, V. C., Goetz, M. B., Ramachandran, V., Brittain, E., Long, M., Nguyen, K., Rodriguez-Barradas, M. C., Budoff, M. J., Tindle, H. A., Samet, J. H., Justice, A. C., & Freiberg, M. S. (2020). FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.. Progress in Cardiovascular Diseases, (). http://dx.doi.org/10.1016/j.pcad.2020.02.010

Peer Reviewed

1